Health Care · Biological Products, (No Diagnostic Substances) · OTC · CIK 836564 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.07Day −86.75%Mkt cap $4M1Y −80.3%Off 52W high −94.6%Vol (1Y) 460.3%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,363 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover8.1d |
| Next report (est.)2026-08-20 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Earnings (TTM)-$681,877 |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−76.6% |
| 1Y−80.3% |
| 3Y−91.4% |
| 5Y−95.4% |
| Since incept. (ann.)−51.1% |
Price return through 2026-07-30 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)460.3% |
| Ann. volatility (3Y)322.7% |
| Sharpe (1Y)1.70 |
| Sharpe (3Y)1.20 |
| Max drawdown (1Y)−94.6% |
| Max drawdown (3Y)−94.6% |
| Beta (3Y vs SPY)−0.12 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for CPMV.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-20 | −$0.02 | — | — | — |
| 2025-09-30 | 2025-11-19 | −$0.02 | — | — | — |
| 2025-06-30 | 2025-08-19 | −$0.02 | — | — | — |
| 2025-03-31 | 2025-05-20 | −$0.03 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-20 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
